23. CURRENT STATUS OF BIOSAFETY IN THE LABORATORY AT THE CAN THO BLOOD TRANSFUSION HEMATOLOGY HOSPITAL IN 2024
Main Article Content
Abstract
Objective: This study aims to describe the biosafety management practices and laboratory biosafety practices of staff at the Can Tho Blood Transfusion Hematology Hospital in 2024.
Subjects and Methods: A cross-sectional descriptive study was conducted involving all laboratory staff and relevant records related to biosafety management.
Results: A survey conducted in four laboratories with 70 staff members revealed several limitations in biosafety management at the hospital. Although the biosafety management system is relatively comprehensive, only three out of four laboratories have designated personnel responsible for biosafety. In terms of infrastructure, only two out of three laboratories fully meet the required standards. Most staff members demonstrate a correct understanding of biosafety regulations and adhere well to personal protective equipment usage; however, proper technical practices in biosafety cabinets are limited, particularly regarding disinfection procedures and cabinet operation protocols.
Conclusion: It is essential to enhance training, supervision, and updating of biosafety regulations, as well as standardize processes and conduct regular
Article Details
Keywords
Biosafety, laboratory, laboratory safety practices, biosafety management.
References
[2] WHO. Cẩm nang an toàn sinh học phòng xét nghiệm ấn bản lần thứ 42020.
[3] Nguyễn Xuân Tùng. Thực trạng và hiệu quả can thiệp đảm bảo an toàn sinh học tại phòng xét nghiệm vi sinh của Trung tâm Y tế dự phòng tuyến tỉnh Viện Vệ sinh Dịch tễ Trung Ương 2015.
[4] Girma M, Deress T, Adane K. Laboratory Quality Management System and Quality Indicators Implementation Status as Perceived by Laboratory Professionals in Preparation for the Accreditation Process from Selected Government Hospitals of Ethiopia. Clinical laboratory. 2020;66(4).
[5] David RE, Dobreanu M. Pre-Analytical Components of Risk in Four Branches of Clinical Laboratory in Romania--Prospective Study. Clinical laboratory. 2016;62(6):1033-44.
[6] Lien A, Abalos C, Atchessi N, Edjoc R, Heisz M. Surveillance des expositions en laboratoire aux agents pathogènes humains et aux toxines, Canada 2019. Relevé des maladies transmissibles au Canada. 2020;46(9):329-36.
[7] Wurtz N, Papa A, Hukic M, Di Caro A, Leparc-Goffart I, Leroy E, et al. Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories. European Journal of Clinical Microbiology Infectious Diseases. 2016;35:1247-58.
[8] Bang E, Oh S, Chang HE, Shin IS, Park KU, Kim ES. Zika Virus Infection During Research Vaccine Development: Investigation of the Laboratory-Acquired Infection via Nanopore Whole-Genome Sequencing. Frontiers in cellular and infection microbiology. 2022;12:819829.
[9] Maniaci A, Fakhry N, Chiesa-Estomba C, Lechien JR, Lavalle S. Synergizing ChatGPT and general AI for enhanced medical diagnostic processes in head and neck imaging. European Archives of Oto-Rhino-Laryngology. 2024;281(6):3297-8.
[10] Smith AM, Smouse SL, Tau NP, Bamford C, Moodley VM, Jacobs C, et al. Laboratory-acquired infections of Salmonella enterica serotype Typhi in South Africa: phenotypic and genotypic analysis of isolates. BMC infectious diseases. 2017;17(1):656.
[11] Sharp TM, Fisher TG, Long K, Coulson G, Medina FA, Herzig C, et al. Laboratory-Acquired Dengue Virus Infection, United States, 2018. Emerging infectious diseases. 2020;26(7):1534-7.
[12] KTN. N. Connaissances et pratiques de la biosécurité dans les laboratoires cliniques de la ville de Kinshasa en République démocratique du Congo: Universitaires Européennes; 2020.